TCR-Tregs for ALS Therapy

Overview

About this study

The purpose of this study is to develop disease-specific Tregs that target specifically antigens involved in ALS pathogenesis and they harbor a lower risk of general immunosuppression.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Mohsen Khosravi Maharlooei, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20579585

Mayo Clinic Footer